722
Y. Kim et al. / Bioorg. Med. Chem. Lett. 12 (2002) 719–722
References and Notes
1. Larock, R. C.; Reifling, B. J. Org. Chem. 1978, 43, 131 and
references therein.
2. Caine, D.; Stephen, F.; Ukachukawa, V. C. J. Org. Chem.
1983, 48, 740.
3. Rao, Y. S. Chem. Rev. 1964, 64, 353.
4. Rao, Y. S. Chem. Rev. 1976, 76, 625.
5. Dungyan, M. T.; Avetisyan, A. A. Russ. Chem. Rev. 1977,
46, 643.
6. Fang, X. P.; Anderson, J. E.; Chang, C. J.; Melaughin, J. L.
Tetrahedron. 1991, 47, 9751.
Figure 3. cis-Restricted five-membered heterocyclic combratastatins.9
7. Kim, Y.; You, Y. J.; Kim, S. B.; Ahn, B. Z. Planta Med. In
press.
8. Nguyen, H. N.; Kim, Y.; You, Y. J.; Hong, D. H.;
Kim, H. M.; Ahn, B. Z. Bioorg. Med. Chem. Lett. 2001,
11, 3073.
angles between the two 3,4-aryl rings in each com-
pound. As shown in Figure 1, the dihedral angles
between the A and B rings in DPT, diaryloxazolone 1
and diarylfuranone 2f were 70.3, 52.6, and 15.4ꢁ. The
potencies of the three compounds were found to be in
the same order (AC values of 11.9, 64.5, and 83.8 nM,
respectively). Thus it seemed that the magnitude of the
dihedral angle between A and B rings positively influ-
enced the bioactivity of the compounds in this series.
9. Ohsumi, K.; Hatanaka, T.; Fujita, K.; Nahagawa, R.;
Fukuda, Y.; Nuhei, Y.; Suga, Y.; Morinaga, Y.; Akiyama, Y.;
Tsuji, T. Bioorg. Med. Chem. Lett. 1998, 8, 3153.
10. Starting material of 2h, 3-benzyloxy-4-methoxy-
acetophenone was synthesized as follows: commercially avail-
able 3-hydroxy-4-methoxybenzaldehyde was treated with
benzylbromide in the presence of anhydrous K2CO3 to give 3-
benzyloxy-4-methoxybenzaldehyde, which was then con-
densed with methylmagnesium bromide to give 1-(3-benzyl-
oxy-4-methoxy)-1-ethanol in 92% yield. Oxidation of the
alcohol group of 1-(3-benzyloxy-4-methoxy)-1-ethanol by
PDC gave a 3-benzyloxy-4-methoxy-acetophenone in 98%
yield.
Previously, Oshumi et al. reported a series of cis-
restricted 5-membered heterocyclic combratastatins,
and observed that substituents as small as –NH2,–CH3,
carbonyl group on position 1or 3 of the five-membered
heterocycles substantially decreased their bioactivity
(Fig. 3).9 In contrast, it was noteworthy that most
compounds in the present series of 3,4-diaryl-2(5H)-
furanones which possess a carbonyl group on position 1
showed very potent cytotoxic activity.
11. Starting material of 2i, 3-nitro-4-methoxyacetophenone
was synthesized as follows: commercially available 3-nitro-4-
hydroxyacetophenone was refluxed with dimethylformamide
(DMF) in the presence of anhydrous K2CO3 to give 3-nitro-4-
methoxyacetophenone in 92% yield.
In conclusion, we have synthesized a series of 3,4-diaryl-
2(5H)-furanone derivatives with potent cytotoxic activ-
ity in tumor cell lines. This is the first report revealing
compound of 3,4-diaryl-2(5H)-furanone type, a class of
compounds well known previously as selective COX-II
inhibitors, with potent cytotoxic activity in tumor cells.
Four compounds in this series including 2c, 2h, 2j and
2k were found to have ED50 value of less than 20 nM in
most of the cell lines assayed. Evaluation of a repre-
sentative compound from this series, compound 2j, in in
vivo model is underway in our laboratory and the
results will be disclosed in due course.
12. All newly synthesized compounds gave satisfactory ana-
lytical and spectroscopic data. 2j: 1H NMR (90 MHz, CDCl3):
d 6.71(dd, J=8.77, 2.15 Hz, 1H), 6.58 (d, J=8.77 Hz, 1H),
6.51(d, J=2.15 Hz, 1H), 6.49 (s, 2H), 5.25 (s, 2H), 3.99 (s,
3H), 3.89 (s, 3H), 3.78 (s, 6H). Anal. (C20H21NO6) calcd: C,
64.68; H, 5.70; N, 3.77; found: C, 64.42; H, 5.64; N, 3.71. 2k:
1H NMR (90 MHz, CDCl3): d 7.88–7.76 (m, 4H), 7.57–7.53
(m, 2H), 7.40 (dd, J=1.78, 8.60 Hz, 1H), 6.72 (s, 2H), 5.30 (s,
2H), 3.89 (s, 3H), 3.70 (s, 6H). Anal. (C23H20O5) calcd: C,
73.39; H, 5.36; found: C, 73.13; H, 5.31.
13. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.;
McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenny,
S.; Boyd, M. R. J. Natl. Cancer Inst. 1990, 82, 1107.